BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 3316472)

  • 1. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
    Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
    J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
    Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
    Murphy WJ; Kumar V; Cope JC; Bennett M
    J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Apr; 165(4):1212-7. PubMed ID: 3549961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of newborn liver cells as a murine model for cord blood cell transplantation.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow graft rejection as a function of antibody-directed natural killer cells.
    Warner JF; Dennert G
    J Exp Med; 1985 Mar; 161(3):563-76. PubMed ID: 2579185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats.
    Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B
    Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine natural killer cells and marrow graft rejection.
    Yu YY; Kumar V; Bennett M
    Annu Rev Immunol; 1992; 10():189-213. PubMed ID: 1590985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine marrow coexpressing H2-Dsp2 and H2-Db on host natural killer cell rejection.
    Liu J; Sentman CL; Kumar V; Bennett M
    Transplantation; 1997 Feb; 63(3):444-9. PubMed ID: 9039937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.